Treatment of refractory heart failure with a percutaneous circulatory support device.

J Cardiovasc Med (Hagerstown)

Division of Cardiology, Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy.

Published: June 2006

End-stage heart failure refractory to medical therapy is a clinical challenge. Heart transplantation is considered the best strategy, but it remains burdened with substantial limitations due to the scanty availability of facilities with a transplant programme, donor shortage, and unpredictable waiting lists. Alternatively, assist devices may allow an improvement of the haemodynamic conditions, modifying the history of end-stage heart failure and introducing new management strategies. The goal of a minimally invasive short-term circulatory support device in the treatment of end-stage heart failure patients awaiting heart transplant is to restore the haemodynamic conditions and to improve end-organ dysfunction, with a low incidence of major adverse cardiac events. This report describes the first implantation in Italy of a new percutaneous circulatory support device, the Cancion cardiac recovery system, in a patient with severe end-stage heart failure listed for transplantation.

Download full-text PDF

Source
http://dx.doi.org/10.2459/01.JCM.0000228698.37773.d2DOI Listing

Publication Analysis

Top Keywords

heart failure
20
end-stage heart
16
circulatory support
12
support device
12
percutaneous circulatory
8
haemodynamic conditions
8
heart
7
failure
5
treatment refractory
4
refractory heart
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!